SIGNALAI·Jun 12, 2026, 4:00 AMSignal55Medium term

Fusion Learning from Dynamic Functional Connectivity: Combining the Amplitude and Phase of fMRI Signals to Identify Brain Disorders

Source: arXiv cs.AI

Share
Fusion Learning from Dynamic Functional Connectivity: Combining the Amplitude and Phase of fMRI Signals to Identify Brain Disorders

arXiv:2603.24603v2 Announce Type: replace-cross Abstract: Dynamic functional connectivity (dFC) derived from resting-state functional magnetic resonance imaging (fMRI) has been extensively utilized in brain science research. The sliding window correlation (SWC) method is a widely used approach for constructing dFC by computing correlation coefficients between amplitude time series of signals from pairs of brain regions. In this study, we propose an integrated approach that incorporates both amplitude and phase information of fMRI signals to improve the detection of brain disorders. Specificall

Why this matters
Why now

Advances in computational neuroscience and AI are enabling more nuanced analysis of complex biological signals like fMRI, pushing the boundaries of diagnostic capabilities.

Why it’s important

This research suggests a more robust method for early and accurate identification of brain disorders, potentially revolutionizing clinical diagnostics and personalized medicine in neurology.

What changes

Traditional fMRI analysis, which primarily uses amplitude, now has a proposed enhancement by integrating phase information, leading to more comprehensive and potentially more accurate diagnostic models.

Winners
  • · Neurology research
  • · Medical AI development
  • · Patients with brain disorders
  • · Diagnostic imaging companies
Losers
  • · Traditional fMRI diagnostic methods
Second-order effects
Direct

Improved early detection and differential diagnosis of complex neurological and psychiatric conditions.

Second

Accelerated development of targeted therapies and interventions for various brain disorders based on more precise diagnostic profiles.

Third

Potential for population-scale screening or preventative measures for neurological diseases, driven by cost-effective and accurate fMRI analysis.

Editorial confidence: 85 / 100 · Structural impact: 40 / 100
Original report

This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.

Read at arXiv cs.AI
Tracked by The Continuum Brief · live intelligence network
Share
The Brief · Weekly Dispatch

Stay ahead of the systems reshaping markets.

By subscribing, you agree to receive updates from THE CONTINUUM BRIEF. You can unsubscribe at any time.